Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Charlottesville Personal Injury Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Personal Injury Law

: Charlottesville Personal Injury Lawyer

Validity of Pfizer Neurontin Drug Study Questioned

By Paul Thomson

ADVERTISEMENTS

Studies on the Pfizer Inc. drug Neurontin may have been skewed in order to have favorable results, reports Bloomberg. The drug is intended to treat epilepsy, however the studies focused on uses for Neurontin that had not yet been approved by the FDA. Researchers found that data from the studies on Neurontin that made its way into medical journals was inconsistent with the actual findings from the trials. Unfortunately, medical professionals assume these publications contain accurate information. What this points to is that Pfizer may have attempted to mislead the medical community about the effectiveness of Neurontin for certain off label uses. Pfizer denies this.

"Physicians are allowed to prescribe drugs for uses not approved by the FDA, and drugmakers are allowed to provide publications about off-label uses," the article states. When they are prescribing drugs for uses not approved by the FDA, studies such as the Neurontin study are doctors only source of information. Drugmakers need to provide accurate information in order to promote the best interests of doctors and patients. Our health depends on drugmakers' reliability!

Originally posted at InjuryBoard by Paul Thomson

Full post as published by Charlottesville Personal Injury Lawyer on November 17, 2009 (boomark / email).